Bennett Allen is a Research Associate with RxStat, an innovative real-time drug surveillance project housed at the New York City Department of Health and Mental Hygiene's Bureau of Alcohol and Drug Use Prevention, Care, and Treatment. He worked previously conducting research at Mount Sinai Beth Israel's Chemical Dependency Institute and holds an MA in Clinical Psychology from the New School for Social Research.
Lindsey Alley, MS, is a Research Associate and Project Manager at HealthInsight Oregon. Ms. Alley received her Master of Science in Applied Psychology at Portland State University, where she gained advanced training in the psychosocial facets of health behavior and health outcomes. Ms. Alley’s work involves a variety of qualitative and quantitative methods, including focus groups, semi-structured interviews, job shadowing, dyadic data collection and analysis, and survey design/distribution. Her research focuses on patient experiences and relationship implications (e.g., spouse-patient, provider-patient, and pharmacist-patient) regarding both treatment facilitation and adherence for individuals living with chronic illness and chronic pain. She has successfully coordinated seven research projects through which she has collected, analyzed, and disseminated data regarding psychosocial determinants of various health-related behaviors including Safe Patient Handling, exercise, drinking, obesity, work-related injuries, and psychological well-being. She is currently managing an AHRQ-funded project to develop and evaluate a toolkit aimed at community pharmacists to facilitate use of the Oregon Prescription Drug Monitoring Program and enhance supportive, effective communication between patients, pharmacists, and prescribers around opioid management.
Cassandra Andersen, is the Manager of Strategic Partnerships with the City of Worcester, Massachusetts, Division of Public Health where she has been employed for over 4 years. The City of Worcester provides public health services to 7 communities in Massachusetts through the Central Massachusetts Regional Public Health Alliance with a combined population of over 283,000 residents. Before joining the City of Worcester she worked in diverse settings across Massachusetts focusing her career on community capacity building and partnership development including promotion of positive youth development, providing technical assistance on developing healthy community coalitions, CBO implementation of evidence based programs and ensuring community engagement in community-based participatory research. She is currently responsible for the management of Community Health staff, overseeing the implementation of grants and initiatives to improve community health and reduce substance misuse related morbidity and mortality across the Central Massachusetts Regional Public Health Alliance. Engaging academic and community partners and advising student research is also an essential component of her work. She is a recipient of the City of Worcester Eleanor Riik Service Excellence Award.
Kristin Ashford, PhD, WHNP-BC, FAAN, Assistant Dean of Research and Women’s Health Nurse Practitioner for the University of Kentucky College of Nursing
Kristin Ashford, PhD, WHNP-BC, FAAN, is the Assistant Dean of Research and Women’s Health Nurse Practitioner for the University of Kentucky College of Nursing. Her primary area of research is perinatal tobacco and substance abuse. She has been a nurse for 25 years and has particular interest in coordination of supportive services for perinatal women with substance use disorders.
Carmen Ashley, MPH, MCHES, Senior Advisor, Substance Use Prevention, Division of Adolescent and School Health, Centers for Disease Control and Prevention
Carmen Ashley is the Senior Advisor for Substance Use Prevention in the Division of Adolescent and School (DASH) Health at the Centers for Disease Control and Prevention (CDC). In this role, she provides oversight and guidance for DASH’s strategic imperative to integrate substance use prevention into HIV/STD prevention efforts for teens. Carmen previously was a Lead Health Education Specialist in DASH, managing technical assistance and other program support offered to education agencies and non-governmental organizations on issues such as sexual risk behavior reduction and coordinated school health. Prior to her work at CDC, Carmen was the Associate Director for Programs and Operations in the applied public health department at Emory University. She has several years’ experience working for other public health agencies such as the American Cancer Society and the South Carolina Department of Health and Environmental Control.
Michael C. Barnes, Esq. is a founder and the chairman of the board of directors of the Center for Lawful Access and Abuse Deterrence. Mr. Barnes is also a practicing attorney and the managing partner at DCBA Law & Policy in Washington, DC. Mr. Barnes has been a member of the advisory board for the National Rx Drug Abuse & Heroin Summit since 2012, has authored more than 10 scholarly articles, and presents frequently at conferences nationwide. He is a contributor to U.S. News & World Report and provides analysis for TV networks including CNBC, CNN, FOX Business, FOX News, and MSNBC. Mr. Barnes previously served as confidential counsel in the White House Office of National Drug Control Policy.
Andrea Grubb Barthwell, M.D., F.A.S.A.M., is the founder and Chief Executive Officer of the global health care and policy-consulting firm EMGlobal LLC and Director at Two Dreams Treatment Centers. President George W. Bush nominated and the United States Senate confirmed her to serve as Deputy Director for Demand Reduction in the Office of National Drug Control Policy (ONDCP) from January 2002 to July 2004. As a member of the President's sub-cabinet, Dr. Barthwell was a principal advisor in the Executive Office of the President (EOP) on policies aimed at reducing the demand for illicit drugs. Dr. Barthwell received a Bachelor of Arts degree in Psychology from Wesleyan University, and a Doctor of Medicine from the University of Michigan Medical School. Dr. Barthwell is a past president of the American Society of Addiction Medicine and in 2003, Dr. Barthwell received the Betty Ford Award, given by the Association for Medical Education and Research in Substance Abuse.
Margaret Baughman, PhD, Senior Research Associate, Begun Center for Violence Prevention Research & Education at the Jack, Joseph and Morton Mandel School of Applied Social Sciences, Case Western Reserve University.
Since 2008, Dr. Baughman has served as the Principal Investigator for thirteen specialty-docket court research evaluations including the State of Ohio’s $5 million dollar Addiction Treatment Project, SAMHSA CSAT and BJA federally-funded Opiate Drug Court projects, Veteran’s Court, Human Trafficking Court and Mental Health Court
evaluations as well. Her research areas include addiction, mental health, criminal justice, community-based treatment, trauma and trauma-informed care. She holds a Ph.D. from The University of Akron in Public Affairs and Urban Studies with a specialization in Program Evaluation where she was an Adjunct Professor teaching
research methods, urban policy and program evaluation courses to graduate students.
Chris Baumgartner is the Drug Systems Director at the Department of Health. Prior to his appointment in 2015, he served in various capacities for 10 years, including working for the Department as the Prescription Monitoring Program Director and owning a consulting firm that provided training and technical services to federal and state governments. He also worked for the WA State Department of Social and Health Services as an IT Portfolio Analyst and managed the Prescription Monitoring Program for the State of Maine while with the Office of Substance Abuse. Mr. Baumgartner holds a Bachelor's of Science Degree from the University of Idaho in Computer Engineering with a Computer Science minor. In 2016 he completed a fellowship with the Informatics Training in Place Program overseen by the Centers for Disease Control and Prevention.
Carla Blanton owns a public relations firm that assists corporations, associations, and nonprofits, including Operation UNITE. She creates Operation UNITE’s social media calendar and posts. Blanton helped coordinate with President Obama’s press office for his appearance at the 2016 National Rx Drug Abuse & Heroin Summit. Operation UNITE, which works in 32 Kentucky counties, pioneered a three-pronged approach to the drug epidemic that involves law enforcement, treatment, and education/prevention. Blanton, who is the former communications director for Governor Ernie Fletcher, also serves as chair of Commerce Lexington (chamber of commerce).
Mary Bono, a former United States congresswoman from California, served in the U.S. House of Representatives from 1998-2013. Since leaving Congress, Mary has developed a robust practice advising businesses and other entities nationwide on legislative, regulatory and policy matters. In Congress, Mary was known for her skill and passion for building bipartisan consensus and developing win-win solutions that benefitted all parties. As a result, legislation she authored was signed into law by Presidents Clinton, Bush and Obama. At FaegreBD Consulting, Mary utilizes the same results-focused approach to help organizations achieve their policy objectives. She has particular expertise in the telecommunications, energy, health care, land management and water policy sectors.
Katherine Boss, MA, Acting Director, Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals
Rebecca Boss, MA, was appointed Acting Director of the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals in June 2016. She has more than 20 years’ experience working directly in the addictions treatment field as both a Clinical Supervisor and Program Director. In 2004, she joined BHDDH and became the Administrator for Substance Abuse Treatment Services. She also served as both National Treatment Network representative for the National Association of State Alcohol and Drug Abuse Directors (NASADAD) and as the State Opioid Treatment Authority. Most recently, Ms. Boss served as the Deputy Director of BHDDH and has broadened her oversight of programs to include the entire behavioral healthcare system. In collaboration with consumers, providers, and the State Medicaid Office, she submitted a State Plan Amendment for the creation of a Health Home designation for Opioid Treatment Providers. She has received two awards for the creation of that program – the 2016 National Treatment Network (NTN) Representative of the Year and the Women’s Health Council of Rhode Island honored her with the 2016 Karen Rosene Montella Spark Award for Innovation in Women’s Health in Rhode Island for her leadership in developing the Anchor ED Program.
I possess a strong background in pharmacist and student pharmacist education innovation, pharmacy-based public health projects, and advocating for regulatory and statutory changes to expand pharmacy practice. As former president of the Rhode Island Pharmacists Association (RIPA), I am well acquainted with the challenges community pharmacists and pharmacies face regarding opioid dispensing, opioid safety, overdose, and addiction. My research interests include expanding pharmacists' roles in public health, particularly in prevention of opioid drug overdose and death, infectious diseases prevention, expansion of immunization practice, and emergency preparedness. I have served as a consultant on a grant examining pharmacy staff attitudes and experiences of selling over the counter syringes to injection drug users and currently serve as an expert on a grant examining methods of connecting HIV positive patients with substance use disorders to pharmacies that dispense naloxone. I consult for prescribetoprevent.org, a website devoted to opioid overdose education and naloxone training. I help implement, expand, and study the outcomes of the Rhode Island Collaborative Pharmacy Practice Agreement for naloxone (CPAN), a partnership between the RI Department of Health, RI Board of Pharmacy, an addiction medicine provider and nearly every Rhode Island Walgreens and CVS pharmacy, totaling 88 pharmacies and almost 350 pharmacists. I am a co-investigator on a 3-year, $1.5 million federal Agency for Healthcare Research and Quality (AHRQ) grant to innovate, test, demonstrate, and catalogue how to optimize pharmacy based naloxone in RI and MA.
Paula Braun, MS Analytics, Entrepreneur-in-Residence, National Center for Health Statistics, Centers for Disease Control and Prevention
Paula Braun is an Entrepreneur-in-Residence at CDC's National Center for Health Statistics (NCHS). She offers a fresh look on how technology can inform and simplify the way mortality data are collected, analyzed, and reported across the United States. She is also a faculty member in public health informatics at Emory University. Prior to her role at CDC, she led complex analytics projects with a federal financial regulator client and prior to that she led large investigations of US Government wartime spending in Iraq and Afghanistan.
Kris Brinkmeier has 20+ years’ experience working in healthcare, human/community service, and public health, with the past 8 years as an employee of the Roane County Anti-Drug Coalition (RCADC) working in the field of prevention. Through the RCADC she has worked with different sectors in the community such as healthcare, law enforcement, schools, and faith-based. She facilitates P3-Postive Peer Pressure Clubs in the middle schools in Roane. These are student leadership clubs focusing on substance abuse, using resources such as the SADD curriculum. She is excited to work within social media channels as much as possible to provide awareness on substance abuse.
Keith Brown joined the Katal Center for Health, Equity, and Justice in May 2016 as Project Director of Albany, NY’s Law Enforcement Assisted Diversion (LEAD) initiative after being an integral part of the stakeholder group that developed the project. He is the former Executive Director of Catholic Charities Care Coordination Services, a multi-faceted agency providing direct services to individuals impacted by HIV and other chronic illnesses, and prevention services for communities and individuals at-risk for HIV, Hepatitis C, and other conditions. The agency’s Project Safe Point Program, founded by Keith in 2010, works to address the complex health and prevention issues faced by people who use drugs, creating a vital link between the community and service continuum. Keith’s expertise in harm reduction, criminal justice reform, population health management and disease prevention has been sought by various groups and organizations working to address the growing epidemics of opiate use and overdose.
Dr. Krista Brucker is a faculty member at the Indiana University School of Medicine's Department of Emergency Medicine and works clinically in the Emergency Department at Eskenazi Health. Dr. Brucker's research focuses on mental health and substance abuse treatment in the Emergency Department setting. Her current work includes the design and implementation of Project POINT, a collaborative effort aimed at identifying, treating and linking patients with opioid misuse disorders to outpatient addiction services. Dr. Brucker completed her emergency medicine residency at the Northwestern University Feinberg School of Medicine in Chicago, IL where, in her final year of training, she served as a Chief Resident.
Administrative Director Michael L. Buenger (BING-URR) is the sixth person to serve in the position established in the 1968 Modern Courts Amendment. He was hired Jan. 5, 2015. As the senior non-elected officer of the Supreme Court, he, along with the Chief Justice and Justices, the Ohio Judicial Conference, and the judges of the state, is responsible for developing and communicating the long-term vision, values, and direction of the Supreme Court and the judicial branch. He brought with him 25 years of experience in judicial administration, legislative affairs, intergovernmental relations, and operations management at several stops including the National Center for State Courts, as a senior rule of law adviser in Kosovo, and as Missouri’s and South Dakota’s state court administrator. His ties to Ohio are strong, having worked for the Second District Court of Appeals in Dayton as Judge Thomas J. Grady’s law clerk and as the administrator/staff counsel for the court following the clerkship. In between working with the courts, he served as an adjunct professor with the University of Dayton and Sinclair Community College and on the drafting team for the Interstate Compact for Adult Offender Supervision and the Interstate Juvenile Compact.
Scott Burris is a Professor of Law and Public Health at Temple University, where he directs Robert Wood Johnson Foundation’s Policy Surveillance and Policies for Action programs. He work focuses on how law influences public health, and what interventions can make laws and law enforcement practices healthier in their effects. Professor Burris is a graduate of Washington University in St. Louis (A.B.) and Yale Law School (J.D.).
Christopher Bush is a current graduate student at the University Of Michigan School Of Public Health in the Epidemiology Methods and Applications program. His public health research interests include prescription drug abuse, specifically among opioids, including intervention, prevention, and surveillance work. Throughout his graduate career he has been involved in prescription drug abuse research including an internship at the CDC's Division of Unintentional Injury Prevention within the National Center for Injury Prevention and Control. Upon completion of his Masters he plans to either pursue his PhD in Pharmaceutical Outcomes, Research, and Policy or enter into the work force with the goal of continuing his work in opioid overdose research.
Alex Cahana, MD, MAS, FIPP, Affiliate Professor in Science, Technology, Education and Health Studies, University of Washington
Alex Cahana, MD, MAS, FIPP, is an Affiliate Professor in Science, Technology, Education and Health Studies; and has served as Chief of the Division of Pain Medicine at the University of Washington. Dr. Cahana has provided his expertise in pain management to the U.S. Department of Defense and the U.S. Veterans Administration. He is a decorated combat medical officer in the Israeli Defense Forces. Dr. Cahana obtained his medical degree from Tel Aviv University. He also holds degrees in Bioethics, Philosophy and Theology and recently received the University of Washington's Presidential David B. Thorud Leadership Award for "exceptional abilities to lead serve and collaborate with broad impact.” He has received the Joint Commission on Accreditation of Healthcare Organization's Best Practice Mention and Honorable Mention for Innovation in Health Care by the Association of American Medical Colleges.
Dr. Dan Calac has served as Chief Medical Officer of the Indian Health Council, Inc. located near San Diego, California since 2003. He was raised on the Pauma Indian Reservation and graduated from San Diego State University. He attended Harvard Medical School, and completed his internship and residency at the University of Southern California-Los Angeles County Combined Internal Medicine/Pediatrics Residency Program. He is board-certified in both Internal Medicine and Pediatrics. He also practices hospice/palliative care medicine and is board eligible in this field. He is a member of the Pauma Band of Luiseno Indians and is actively involved in his community. His professional interests include chronic disease and clinical research. Dr. Calac serves as the Principal Investigator for the California Native American Research Center for Health which is an National Institutes of Health funded project providing a platform for community based participatory research in American Indian communities. He is actively engaged in several research projects which aim to improve the health of American Indians and encourage students to pursue careers as scientists and/or health care professionals. Dr. Calac also serves on a variety of committees including the Health Research Advisory Council for the Dept of Health and Human Services, the Committee on Native American Child Health, Cal State San Marcos Foundation Board, and the governance board for the All Tribes American Indian Charter School. He also enjoys hiking, backpacking, spending time with his four children and wife Jacqueline of 24 years.
Deepa Camenga, MD, MHS, Assistant Professor, Departments of Emergency Medicine and Pediatrics, Yale School of Medicine
Dr. Deepa Camenga is an Assistant Professor of Emergency Medicine and Pediatrics at the Yale School of Medicine and is board certified in pediatrics and addiction medicine. Dr. Camenga practices in primary care and addiction medicine specialty clinics. She precepts residents and students in the Yale -New Haven Hospital Primary Care Center and worked to include standardized screening for tobacco and other substance use for all adolescent well visits. Her research focuses on improving primary care practices around the identification and treatment of tobacco and substance use disorders in adolescents and young adults, and understanding how youth use electronic cigarettes. She completed her medical education and residency training at the University of Rochester, and fellowship in health services research through the Robert Wood Johnson Foundation Clinical Scholars Program at Yale.
Melinda Campopiano, MD, Medical Officer, Division of Pharmacologic Therapies, Branch Chief for Regulatory Programs, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration
Dr. Campopiano is a medical officer in the Division of Pharmacologic Therapies and Branch Chief for Regulatory Programs at the Center for Substance Abuse Treatment which is part of the Substance Abuse and Mental Health Services Administration. Her activities have included development of SAMHSA’s Opioid Overdose Prevention Toolkit, Brief Guides on Medication for the Treatment of Alcohol Use Disorder and the Clinical Use of Extended-Release Injectable Naltrexone in the treatment of Opioid Use Disorder, and the recent Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder. She served as chairperson for the Treatment and Recovery Committee of the National Heroin Taskforce in 2015.
Originally from Iowa Dr. Campopiano is a graduate of the University of Pittsburgh School of
Medicine. She is board certified in Family Medicine and Addiction Medicine. She provided primary care and buprenorphine services in her solo practice in Pittsburgh and was medical director of Western
Psychiatric Institute and Clinic’s Opioid Addiction Treatment Program prior to coming to SAMHSA.
Neely C. Carlton is a Senior Counsel at Butler Snow, LLP. Ms. Carlton began her 20+ year legal and political career in 1994 when she made history at age 25 and became the youngest ever-elected State Senator representing counties Bolivar, Washington, and Sharkey, Mississippi (1996-2004). She has served in all three branches of state government. In 2010, Ms. Carlton led efforts to address internet pharmacy diversion in Mississippi. In 2011, working with the MS Bureau of Narcotics, Ms. Carlton helped coordinate a legislative coalition to require a Rx for Pseudoephedrine in order to stop meth labs. And from 2012-2014, she worked with stakeholders to host a Rx Drug Summit addressing the epidemic of prescription drug abuse, served as an advisor to the MS Prescription Monitoring Program, and helped establish requirement for prescribing continuing education. Ms. Carlton was General Counsel and Chief of Staff at the MS State Medical Association (2009-2014) and in this capacity served as General Counsel to the MS Professionals Health Program. Ms. Carlton routinely advocates for People in Recovery personally and assists advocacy organizations by developing public policy strategies and coalitions for engaging the public and policy makers. Ms. Carlton is an Advisor to the Mississippi ReEntry Council.
Mattie Castiel, MD, was appointed as the City of Worcester’s Commissioner for Health and Human Services in September of 2015. She oversees the divisions of Public Health, Youth Services, Human Rights and Disabilities, Veterans Affairs, and Elder Affairs, and Homelessness along with advancing important new initiatives that fall under the scope of youth violence and the current opioid crisis. Dr. Castiel has worked in the Worcester community as a board certified internist for over 26 years. She has worked at UMass Memorial Medical Center and Family Health Center of Worcester and also as an Associate Professor of Internal Medicine, Family Medicine and Psychiatry at UMass Medical School. In 2009, Dr. Castiel founded the Latin American Health Alliance (LAHA), a nonprofit organization in Worcester dedicated to combating homelessness and drug addiction. LAHA’s programs consist of the Hector Reyes House and Casa Reyes, a substance abuse treatment facility and transitional house for Hispanic males. Last year, LAHA opened Café Reyes on Shrewsbury Street, an innovative jobs training program for the residents at Hector Reyes House and Casa Reyes. At present she continues to serve as its Medical Director.
Quintin T. Chipley, MA, MD, PhD, Counseling Coordinator, Medical Student Affairs, University of Louisville School of Medicine
Quintin T. Chipley was born in Memphis, Tennessee. He answers best to the nickname, Quinn. He earned his B.A. in Houston, Texas with a double-major in history and Russian language. Thereafter he served as a volunteer English teacher for several years in Kenya, which location afforded him the opportunity to learn Kiswahili. Upon return to the U.S, he next earned the M.Div. with emphasis in biblical languages and church history, then the M.A. in clinical psychology, later the M.D. degree, and lastly a Ph.D. with the interdisciplinary dissertation, “William Faulkner and Alcoholism: Distilling Facts and Fictions.” He has served ten years in the profession of psychology as the Counseling Coordinator for students at the Health Science Center Campus, University of Louisville. In summer 2016, he volunteered for five weeks as language-liaison for U of L medical clinic teams in the Mufindi region of Tanzania. Over the last ten years, he has served as a volunteer board member on several different non-profit agencies dedicated to restoring people who suffer from alcoholism and/ or addiction to lives of sober health.
Dan Ciccarone, MD, MPH, Professor of Family and Community Medicine, University of California, San Francisco
Daniel Ciccarone, MD, MPH, is a Professor of Family & Community Medicine at the University of California at San Francisco. In addition to being a researcher he is a primary care physician and medical educator. Dr. Ciccarone has been principal or co-investigator on numerous NIH sponsored research projects in the areas of public health and HIV/AIDS prevention. His population-based studies, utilizing both quantitative and qualitative methodologies, aim to deepen our understanding of HIV and related disease and risk-taking among socially marginalized groups, e.g., injection drug users. Dr. Ciccarone’s recent NIH/NIDA-funded Heroin Price Purity and Outcomes study explored the medical consequences of distribution and use of the two main source-forms of heroin in the U.S. (Mexican-sourced “black tar” heroin and Colombian-sourced powder heroin). He is currently leading the Heroin in Transition study with its integrated multidisciplinary – ethnographic, epidemiological, economic and statistical modeling – aims to examine the recent rise in heroin use and the expanding diversity of heroin source-forms and illicitly-made synthetic opioids (e.g. fentanyls) and their relationship to sharp increases in illicit opioid-involved morbidity and mortality. His publications have appeared in JAMA, NEJM, AJPH, IJDP and PLoS Medicine and he is currently Associate Editor for the International Journal of Drug Policy.
Dr. Kelly Clark has focused her career on issues of addictive disease, evidence informed behavioral health care, and payment reform. She is Chief Medical Officer of CleanSlate Centers, a multi-state medical group currently treating over 6,000 opioid addicted patients with medication management which has received a SAMHSA Science to Service Award for Office Based Opioid Treatment and a Center of Excellence Award from the Commonwealth of Pennsylvania. She is active on the Association of Managed Care Pharmacy’s Addiction Treatment Advisory Group and as a member of the American Psychiatric Associations Integration Work Group; served on the writing committee of the Johns Hopkins Bloomberg School of Public Health’s recent policy document, “The Prescription Drug Epidemic: An Evidence Based Approach” ; as expert to the National Safety Council, the United States Comptroller General, and the US Attorney General’s office in Kentucky, where she is past president of the Kentucky Society of Addiction Medicine; and led the workgroup on Health Systems and Reimbursement at SAMHSA’s Buprenorphine Summit. Dr. Clark earned an MBA from The Fuqua School of Business at Duke University and her medical degree from the University of Wisconsin. She continues her work as a founding member of the Advisory Board of the National Rx Drug Abuse and Heroin Summit.
Heather Clayton, PhD, MPH, Health Scientist, Survey Operations and Dissemination Team, Division of Adolescent and School Health, Centers for Disease Control and Prevention
Heather is a Health Scientist in Division of Adolescent and School Health at the Centers for Disease Control and Prevention. As a scientist on the Survey Operations and Dissemination Team, she is focused primarily on the dissemination of data from the three surveillance systems conducted by DASH: (1) the Youth Risk Surveillance System, (2) the School Health Policies and Practices Study and (3) School Health Profiles. As a scientist, Heather conducts research on substance use and sexual risk behaviors among youth. Heather has a Ph.D. in Public Health (concentration – Maternal and Child Health) from the University of South Florida, College of Public Health. She also has an M.P.H. in Epidemiology from San Diego State University, and a Bachelor’s degree in Environmental Health from the University of California, Irvine. She was a member of the 2010 Epidemic Intelligence Service (EIS) class.
Trent Coffey, BA, CPS II, is Executive Director of Schools Together Allowing No Drugs (STAND), a community-based coalition organized to combat youth drug and alcohol abuse. He holds a Bachelor’s degree from the University of Tennessee and has been a strong partner for change in Eastern Tennessee prevention for more than seventeen years. He is a charter member of the Tennessee Certification Board, which brought recognition and certification to prevention professionals throughout the state of Tennessee.
Angela Colistra, PhD, CAADC, CCS, LPC, Assistant Clinical Professor, Behavioral Health Department, College of Nursing and Health Professionals, Drexel University
Dr. Angela Colistra is an Assistant Clinical Professor at Drexel University in the Department of Behavioral Health Counseling. She has sixteen years of combined experience as a counselor, Substance Use Disorder (SUD) counselor, clinical supervisor, researcher, and academic. Algela has worked with individuals managing co-occurring disorders in a variety of treatment settings. Her work in Kathmandu, Nepal and Beijing, China, under the direction of the late Dr. David Powell, focused on the training and certification of the substance use disorder workforce and gained her recognition from the United States Embassy. Angela has presented her work nationally and internationally on numerous topics which include: multicultural competence in clinical supervision, advanced group work skills for counselors, spiritual well-being of substance use disorder counselors, the intersect between addiction and poverty, motivational interviewing, and ethics. Dr. Colistra’s research focus and recent publications are focused on best practices in substance use disorder treatment, developing an opioid intervention and prevention training, addiction related cognitive impairment, multicultural competence in clinical supervision, group counseling techniques, the relationship between SUD counselor’s spiritual well-being and burnout. She is an editorial review board member for the Counseling and Values Journal and the Journal of Addictions and Offender Counseling.
Tammy L. Collins, PhD, Certified Prevention Specialist, Vice President of Research and Program Design, WestCare Foundation
Tammy L. Collins, PhD, a certified prevention specialist, is Vice President of Research and Program Design for WestCare Foundation, a national behavioral health nonprofit. She brings more than 20 years of experience in translating research into practice and policy in the fields of substance misuse, mental health, justice, and education to her role. Dr. Collins also serves as a subject matter expert for national projects including prevention credentialing and as a consultant for statewide and local program development. Her doctorate of philosophy in human development and family science with a cognate area of adolescent behavioral health risk and protective factors was earned from Ohio State University, and she holds a master of arts in counseling and bachelor of arts in journalism/public relations from Marshall University. Prior to her position with WestCare, Dr. Collins led administrative and applied research teams at Ohio and West Virginia state agencies and universities.
Wilson Compton, MD, MPE, Deputy Director of the National Institute on Drug Abuse (NIDA), National Institutes of Health
Wilson M. Compton, MD, MPE, is Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health. NIDA supports most of the world’s research on health aspects of drug abuse and addiction related to preventing drug abuse, treating addiction and addressing serious health consequences of drug abuse, including related HIV/AIDS and other conditions. Dr. Compton received his undergraduate education at Amherst College and his medical education at Washington University in St. Louis. Over his 25 year career, Dr. Compton has achieved multiple scientific accomplishments. He is author of more than 150 articles; is an invited speaker at multiple high-impact venues, and has received multiple awards. Of note, Dr. Compton received the Health and Human Services Secretary’s Awards for Meritorious Service in 2013 and Distinguished Service in 2014.
LeShaundra Cordier, MPH, CHES, is the Communications Team Lead for the Center for Disease Control and Prevention's National Center for Injury Prevention and Control's Division of Unintentional Injury Prevention (DUIP). In this role Ms. Cordier provides guidance on the planning, implementation and evaluation of health communication and marketing activities for the division. Previously, she has worked as a health communication specialist at CDC with the National Center for Environmental Health, Division of Laboratory Sciences, and with the Office of Public Health Preparedness and Response in the Division of Emergency Operations. Ms. Cordier has a bachelors in psychology and a minor in mass communications from the University of Georgia, and researched non-verbal communication. She also hold a master's of public health with a specialization in maternal and child health from the University of Georgia.
Dr. Agatha Critchfield is an Assistant Professor of Obstetrics and Gynecology at the University of Kentucky and is board certified in general obstetrics and gynecology and maternal-metal medicine. She is a native of Lexington, Kentucky, and completed her medical school training at the University of Kentucky College of Medicine. She then went on to complete ob-gyn residency at Brown University and fellowship in maternal-fetal medicine at Tufts University. She has a clinical and research interest in perinatal substance abuse and serves as the medical director of PATHways – a University of Kentucky-based multidisciplinary substance abuse program for pregnant and newly parenting women in the Eastern Kentucky region. Dr. Critchfield is involved in several research projects related to this subject and has spoken regarding the treatment of perinatal substance abuse both locally and nationally.